SEC Form 4 · accession 0001104659-15-029083

Ophthotech Corp. · OPHT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — President · Director

Period of report

Apr 17, 2015

Accepted (ET)

Apr 21, 2015 · 5:11 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001410939

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Apr 17, 2015	M	12,000	$1.593	A	12,000	D
Common Stock^F2	Apr 17, 2015	S	11,300	$50.43	D	700	D
Common Stock^F3	Apr 17, 2015	S	700	$51.09	D	0	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right To Buy)^F4	$1.593	Apr 17, 2015	M	12,000	D	—	May 17, 2020	Common Stock	12,000	459	D

F1The exercises and sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2015.
F2These shares were disposed of in multiple transactions on April 17, 2015 at actual sales prices ranging from $50.01 to $50.89 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3These shares were disposed of in multiple transactions on April 17, 2015 at actual sales prices ranging from $51.03 to $51.14 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4This option was granted on May 18, 2010 and is currently exercisable for all shares underlying the option.